Your shopping cart is currently empty

HNF4A-IN-1 (Compound 17) is an inhibitor of hepatocyte nuclear factor 4α (HNF4A). It demonstrates potent anticancer activity against human head and neck squamous cell carcinoma (SCC131 cells) without exhibiting toxicity to normal cells. HNF4A-IN-1 effectively inhibits the growth of SCC131 cells with an IC50 of 1.75 μM, inducing apoptosis and G2/M cell cycle arrest. Additionally, it facilitates tumor regression in SCC131 xenograft mouse models.
| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | 10-14 weeks | 10-14 weeks | |
| 50 mg | Inquiry | 10-14 weeks | 10-14 weeks |
| Description | HNF4A-IN-1 (Compound 17) is an inhibitor of hepatocyte nuclear factor 4α (HNF4A). It demonstrates potent anticancer activity against human head and neck squamous cell carcinoma (SCC131 cells) without exhibiting toxicity to normal cells. HNF4A-IN-1 effectively inhibits the growth of SCC131 cells with an IC50 of 1.75 μM, inducing apoptosis and G2/M cell cycle arrest. Additionally, it facilitates tumor regression in SCC131 xenograft mouse models. |
| Molecular Weight | 358.32 |
| Formula | C19H13F3N2O2 |
| Cas No. | 2408759-14-6 |
| Smiles | O=C1N[C@H](NC=2C1=CC(OC(F)(F)F)=CC2)C3=CC4=C(C=C3)C=CC=C4 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.